Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001926254-26-000020

Chief Executive Officer acquired 1,159 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hackman Jeffrey S. · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-31 Grant or award : show line 1 in the form +1,159 70,844 D
Loading xslF345X06/form4-11022026_091107.xml…